Background: Today
opioids are used to control and relieve acute and chronic pain. However, the
incidence of both tolerance and dependence phenomena are the two major problems
in the people who take these drugs. So, in this study the combination effect of
haloperidol and methadone on the acquisition and expression of morphine
dependence and tolerance have been examined.
Methods: In this
experimental study ninety-eight NMRI male mice were randomly divided into
acquisition and expression groups. Each group was divided into seven
sub-groups: control, sham (saline), methadone, haloperidol, haloperidol + methadone,
methadone + haloperidol ratio of 2 to 1 and methadone + haloperidol ratio of 1
to 2. All groups were addicted with gradually increasing doses of morphine for
7 consecutive days. All drugs, in the acquisition group were injected 30
minutes before morphine injection for 7 days and in the expression group 30
minutes before morphine injection on the 8th day (test day). Morphine tolerance
was measured by tail immersion test for 30 minutes before and after
administration of morphine on the test day. To assess the dependence, mice were
administered with naloxone and then withdrawal behaviors were observed for 30
minutes. Then data were analyzed using one-way ANOVA by sigma stat software.
Results: Chronic morphine injections induced
tolerance and dependence in mice. Percentage of Maximal Possible Effect (MPE)
as a tolerance index was significantly increased in acquisition and expression
groups which received drugs combination methadone 1 + haloperidol 2 as compared
to control groups. About the dependence, the marked decrease was shown in
withdrawal behaviors in the combination therapy groups.
Conclusions: However, our
results have shown that probably methadone and haloperidol combination
treatment, especially in the ratio of 1 to 2 could reduce tolerance and
dependence more than single drug treatment animal groups.
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |